Marc Glovinsky, DPM
Foot Surgery · Metairie, LANPI 1255330551
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $4,240 of the $6,818 with a category attached, or 62.2%. 17 manufacturers reported payments, led by Stryker at 58.9% of the total. Reporting peaked in 2023 at $2,161 and has fallen 83.7% since, to $351 in 2025.
Across 76 payments — averaging $89.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$4K
- Treace Medical Concepts, Inc.$1K
- Arthrosurface Incorporated$740
- Bone Support Inc.$143
- Zimmer Biomet$125
- Averitas Pharma Inc.$125
- plus $339 from 11 others
What the payments were for
- Travel & lodging$4,24062%
- Food & beverage$2,57738%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 47 | $4,017 |
| Treace Medical Concepts, Inc. | 6 | $1,330 |
| Arthrosurface Incorporated | 6 | $740 |
| Bone Support Inc. | 1 | $143 |
| Zimmer Biomet | 2 | $125 |
| Averitas Pharma Inc. | 1 | $125 |
| Medline Industries LP | 1 | $124 |
| Boston Scientific | 2 | $36 |
| Johnson & Johnson | 2 | $35 |
| ALON Medical Technology | 1 | $28 |
| Medtronic | 1 | $25 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $19 |
| AbbVie | 1 | $18 |
| Alfasigma USA, Inc. | 1 | $17 |
| Advanced Oxygen Therapy Inc. | 1 | $13 |
| Merck | 1 | $13 |
| Smith+Nephew | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$1,188
- AUGMENT INJECTABLE$1,014
- AXSOS$1,014
- VARIAX$1,014
- HOFFMANN$1,014
- GAMMA$1,014
- PROstep$1,010
- HemiCAP MTP Resurfacing$512
- ORTHOLOC 2 LAPIFUSE$424
- ASNIS$169
- PROSTEP MICA$161
- CERAMENTBONE VOID FILLER$143
- CERAMENT G$143
- EASYFUSE$130
- Qutenza$125
- ANCHORAGE$103
How this compares
Too few foot surgery providers in Louisianato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| QutenzaCapsaicin/Skin Cleanser | 20 | $72,202 |
| Ciclopirox | 321 | $9,881 |
| Ammonium Lactate | 307 | $6,918 |
| Ketoconazole | 97 | $1,828 |
| Diclofenac Sodium | 41 | $1,068 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 41 | $473 |
| Betamethasone Valerate | 15 | $457 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 42 | $280 |
| Mupirocin | 27 | $243 |
| Clotrimazole | 11 | $215 |
| Nystatin | 12 | $174 |
| Terbinafine Hcl | 17 | $152 |
| Ciprofloxacin Hcl | 17 | $151 |
| Meloxicam | 13 | $20 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Metairie
- Maria MarkiewiczMetairie$8K
- Robert KadishMetairie$4K
- Cyril ScullyMetairie$1K
- John FasickMetairie$16
- Maria SaucierAlexandria$7K
- Denardo DunhamNew Orleans$5K
- Darren VigeeLacombe$5K
- Gregory BryanShreveport$4K
- Richard DrummondShreveport$3K
- Laurence WelkerShreveport$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.